Federated Hermes’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-11,832
| Closed | -$227K | – | 2160 |
|
2022
Q2 | $227K | Sell |
11,832
-12,380
| -51% | -$238K | ﹤0.01% | 1514 |
|
2022
Q1 | $1.12M | Buy |
24,212
+8,392
| +53% | +$389K | ﹤0.01% | 1204 |
|
2021
Q4 | $1.12M | Buy |
15,820
+2,273
| +17% | +$161K | ﹤0.01% | 1232 |
|
2021
Q3 | $1.58M | Sell |
13,547
-52
| -0.4% | -$6.06K | ﹤0.01% | 1117 |
|
2021
Q2 | $2.13M | Buy |
13,599
+7,268
| +115% | +$1.14M | ﹤0.01% | 1075 |
|
2021
Q1 | $1.2M | Buy |
6,331
+6,038
| +2,061% | +$1.14M | ﹤0.01% | 1302 |
|
2020
Q4 | $37K | Buy |
293
+26
| +10% | +$3.28K | ﹤0.01% | 1847 |
|
2020
Q3 | $29K | Hold |
267
| – | – | ﹤0.01% | 1850 |
|
2020
Q2 | $32K | Sell |
267
-16
| -6% | -$1.92K | ﹤0.01% | 1813 |
|
2020
Q1 | $28K | Sell |
283
-14
| -5% | -$1.39K | ﹤0.01% | 1752 |
|
2019
Q4 | $72K | Sell |
297
-68
| -19% | -$16.5K | ﹤0.01% | 1706 |
|
2019
Q3 | $60K | Buy |
365
+133
| +57% | +$21.9K | ﹤0.01% | 1702 |
|
2019
Q2 | $55K | Buy |
+232
| New | +$55K | ﹤0.01% | 1662 |
|